By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Traversa Therapeutics, Inc. 

505 Coast Boulevard South
Suite 402
La Jolla  California  92037-4613  U.S.A.
Phone: 858-488-6504 Fax: n/a


SEARCH JOBS








Company News
Ex-Traversa Therapeutics, Inc. CEO Arrested in Shooting Spree 9/20/2013 11:00:39 AM
Traversa Therapeutics, Inc. and Sanofi-Aventis K.K. Enter into a Research Agreement for the Development of Traversa's RNAi Delivery Technology 3/25/2010 10:30:31 AM
Company Profile for Traversa Therapeutics, Inc. 1/8/2010 9:37:42 AM
Traversa Therapeutics, Inc. Appoints Curt W. Bradshaw, Ph.D. as VP of Research & Development 1/6/2010 12:04:58 PM
Traversa Therapeutics, Inc. Completes Series B Financing; Raises $5 Million 4/2/2009 10:54:50 AM
Traversa Therapeutics, Inc. Announces Appointment of William G. Kaelin, Jr., M.D. and Yitzhak Tor, Ph.D. to the Company’s Scientific Advisory Board 3/24/2009 11:49:43 AM
Traversa Therapeutics, Inc. Announces Appointment of Barry Toyonaga Ph.D. as Senior Vice President, Business Development 4/21/2008 3:06:08 PM
Company Profile for Traversa Therapeutics, Inc. 4/17/2008 3:20:24 PM
Traversa Raises $2M to Advance RNAi Delivery in Angel-Led Series A Financing 2/4/2008 9:19:39 AM
//-->